Basecamp Wealth Advisors’s STAAR Surgical STAA Stock Holding History

Basecamp Wealth Advisors’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27	Closed	-$623	–	2154
2025 Q4	$623	Buy	+27	New	+$696	﹤0.01%	1588

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIM

Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Basecamp Wealth Advisors's STAA Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 27 shares — an estimated $623 sold.

Basecamp Wealth Advisors first reported a position in STAA in Q4 2025 and held it in 1 quarter. The position peaked at $623 in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

Basecamp Wealth Advisors reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
Basecamp Wealth Advisors sold 27 STAAR Surgical shares in Q1 2026, an estimated $623.
Basecamp Wealth Advisors first reported a position in STAAR Surgical in Q4 2025 and held it in 1 quarter.
Basecamp Wealth Advisors's STAAR Surgical position peaked at $623 in Q4 2025.
187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.